Reactions Weekly

, Volume 1658, Issue 1, pp 188–188 | Cite as

Erlotinib/lumretuzumab

Rash and diarrhoea: 2 case reports
Case report
  • 21 Downloads

Reference

  1. Han J-Y, et al. EGFR and HER3 inhibition-a novel therapy for invasive mucinous non-small cell lung cancer harboring an NRG1 fusion gene. Journal of Thoracic Oncology : Jan 2017 [abstract] - South KoreaGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations